The State Street Health Care Select Sector SPDR ETF seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index (the "Index").The Index seeks to provide an effective representation of the health care sector of the S&P 500 Index.Seeks to provide precise exposure to companies in the pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology industries.Allows investors to take strategic or tactical positions at a more targeted level than traditional style based investing.
State Street Health Care Select Sector SPDR ETF · Issued by SPDR
| LLY | Eli Lilly and Co | 14.87% |
| JNJ | Johnson & Johnson | 10.40% |
| ABBV | AbbVie Inc | 7.36% |
| MRK | Merck & Co Inc | 5.93% |
| UNH | UnitedHealth Group Inc | 5.75% |
| AMGN | Amgen Inc | 3.77% |
| TMO | Thermo Fisher Scientific Inc | 3.73% |
| ABT | Abbott Laboratories | 3.12% |
| GILD | Gilead Sciences Inc | 2.95% |
| PFE | Pfizer Inc | 2.64% |

The Boring Company is reportedly raising $4 billion at a $20 billion valuation -- nearly four times its 2022 price tag -- as its Vegas Loop prepares to expand to the airport. Neuralink's brain-computer interface is now implanted in 21 patients, and the company is targeting $1 billion in annual revenue by 2031, pending FDA approval.